Research & Development Pipeline
We are building a pipeline of transformative technologies based on our unique target of cell stress.
Early stage therapeutics and diagnostics
A therapeutic target (ADC/Antibody:immunotoxin) for treatment of one of the most recalcitrant cancers, Glioblastoma Multiforme is currently under development with two globally recognised universities in Australia and Germany.
A theragnostic technology for sensitive imaging of PCD in patients and whole organisms , eg PET scanning.
CalRexin™ Imaging & Diagnostic Agents
CalRexin™:PET (Positron Emission Tomography) The potential for whole-body imaging of patients to identify programmed cell death, rather than having to remove cells from the body (biopsy), improves quality of life of cancer patients following radio- and chemotherapy treatment. CalRexin™:PET is an example of one of the diagnostic applications.